MENU
Language Selection
EN FR TR RU
Emsey Hospital
Medical Units
Urology

Urology

At Emsey Hospital’s Urology Department, high-quality urological examination, diagnostic, and treatment services are provided to both adult and pediatric patients by a dynamic healthcare team that keeps up with the latest developments. Our urologist aims to deliver competent urology services by utilizing their clinical experience and knowledge based on scientific studies and research.

Prostate Cancer

The prostate is a gland found only in men. It is about the size of a walnut and is located just in front of the rectum, inside the body, and just below the base of the penis. The prostate surrounds the inner part of the urethra, which carries urine and semen out of the penis. One of the functions of the prostate gland is to produce part of the seminal fluid, which keeps sperm alive and protected. The cells that make up the prostate gland tissue grow and remain healthy under the influence of testosterone, the primary male hormone. The general term for all male hormones is androgens.

Prostate cancer cells develop from the cells of the prostate gland. Almost all prostate cancers originate from glandular tissue (adenocarcinoma). Prostate cancer generally develops very slowly within the prostate gland and, as it progresses, eventually penetrates the outer surface of the prostate. It can also directly spread to the tissues of neighboring organs. Ultimately, it may spread to distant tissues in the body, particularly to the bones (metastasis — the spread to other tissues directly or through the lymphatic system and bloodstream). If prostate cancer spreads, it first tends to travel through the lymphatic channels to the lymph nodes in the pelvic region.

 

Lymphatic tissue contains a colorless, transparent fluid rich in immune system cells. Lymphatic vessels carry this fluid to the lymph nodes. Cancer cells can enter the lymphatic vessels, pass into the lymph nodes, and continue to spread from there. If prostate cancer cells reach the lymph nodes, they may also spread to other organs in the body.

Prostate Cancer Symptoms

Unfortunately, in many patients, prostate cancer may not cause any symptoms until the later stages and may not lead to any complaints at all. For this reason, it is very important for you and other male family members over the age of 40 to see a doctor for this disease and to undergo regular check-ups in the following years. Symptoms usually appear only after the urinary tract becomes obstructed. If you experience any of the complaints listed below, you should consult a doctor immediately:

 

  • Frequent urination

  • Difficulty urinating

  • Thin and intermittent urine flow

  • Pain or burning sensation during urination

  • Blood in the urine

  • Pain in the back, hips, or lower back

  • Presence of blood or pus in the urine

  • Blood in the semen and pain during ejaculation

Prostate Cancer Treatment

  • Radical prostatectomy: retropubic – perineal, laparoscopic, robotic

  • Radiotherapy: external – brachytherapy

  • Hormonal therapy: surgical castration – medical castration

  • Chemotherapy

  • Cryotherapy

 

The most important criteria in determining the treatment option are:
The patient’s overall condition, PSA level, cellular characteristics in the biopsy (Gleason score), and the stage of the cancer. In light of all these findings, urology specialists determine and apply the most appropriate treatment method for the patient.

Thulium Laser (ThuLEP) Technology In Prostate Treatment

The prostate is a small gland in the male reproductive system located just below the bladder. Enlargement of the prostate is common with aging and is called benign prostatic hyperplasia (BPH). BPH can cause symptoms such as difficulty urinating, frequent urination, and weak urine flow.

ThuLEP is a modern, minimally invasive technology used in the treatment of the prostate. This treatment method is effectively applied in conditions such as benign prostatic hyperplasia (BPH).
Among other laser treatment methods, such as HoLEP, ThuLEP is one of the most effective options.

Advantages Of Thulium Laser Treatment:

  • Very low risk of bleeding during and after the operation

  • Much faster recovery period compared to other methods

  • Very low risk of damage to surrounding tissues

  • Long-term complications such as urinary incontinence and sexual dysfunction are very rare

  • Almost no risk of the prostate growing back

Recovery process after Thulium laser treatment:
After ThuLEP, patients can usually start eating and drinking fluids within 4–6 hours. As there is no open wound or incision, this treatment does not require dressing, and the patient can be discharged once the urinary catheter is removed and they are able to urinate.

Minimal tissue damage allows for a faster recovery, shortens the hospital stay, and reduces the risks of bleeding, urinary incontinence, and sexual dysfunction.

 

Thulium laser technology is also used not only for prostate enlargement but also in the treatment of bladder and urinary system stones, as well as upper urinary tract tumors. This technology enables the complete removal of cancerous tissue and allows for more accurate pathological examination.

"HoLEP" Method in the Treatment of Prostate Enlargement

In the treatment of prostate enlargement, especially for large prostates, the most suitable method is HoLEP. Although prostate volume is not a strict criterion for surgery, HoLEP is one of the minimally invasive surgical methods that can be performed safely and successfully for both large and small prostate enlargements. The greatest advantage of HoLEP, performed with laser technology, is that the risk of the prostate growing back is almost nonexistent.

HoLEP is performed in an operating room under spinal anesthesia (numbing from the waist down) or general anesthesia. A very thin instrument is inserted through the urethra to reach the prostate, and with the help of a special device called a morcellator, the entire prostate tissue is removed in very small pieces through the urinary tract.

When performed by experienced surgeons, HoLEP surgeries do not cause urinary incontinence because the muscles responsible for continence are not interfered with. The risk of damage to sexual functions is very low, and patients do not experience erectile dysfunction. There is also no risk of damaging tissues surrounding the prostate during surgery, as the holmium laser affects tissue only up to 0.4 mm.

After surgery, a catheter is kept in place for 24 hours, and once removed, any burning sensation during urination also resolves.

HoLEP can be safely applied to most patients with prostate enlargement, including those who:

  • Do not improve after medication

  • Have difficulty urinating

  • Have kidney swelling due to obstruction caused by the prostate

  • Have bladder stones

  • Suffer from recurrent urinary tract infections

  • Have recurrent prostate enlargement after previous surgery

Advantages of HoLEP for patients:

  • Low risk of complications during and after the procedure

  • First-choice method for prostates with a volume of 80 ml or more

  • No need to discontinue blood-thinning medications before surgery

  • Low risk of bleeding

  • Lower cancer risk assessment is possible, as the prostate tissue is excised rather than vaporized, allowing for easy pathological examination

 

After surgery, patients typically stay in the hospital for two days. The first follow-up examination is scheduled three weeks after surgery. If the patient’s condition is good, subsequent routine check-ups are performed at the third month, sixth month, and one year after the operation, followed by annual urology check-ups.

Prostate Enlargement

Benign Prostatic Hyperplasia (BPH) is one of the most common conditions affecting middle-aged and older men. Its prevalence increases with age. Surgical intervention is required in approximately 20% of patients, while 80% are recommended follow-up and medication.

BPH symptoms, such as frequent urination, nocturia (waking up at night to urinate), and incomplete bladder emptying, progress slowly but can lead to a decline in quality of life. The prostate, which enlarges under the influence of testosterone (the male sex hormone), narrows the urinary passage running through it, causing intermittent urination and a weakened urine stream.

Symptoms
In BPH, a group of complaints known as lower urinary tract symptoms (LUTS) appear:

  •  

    Weak urine stream

  • Intermittent urination

  • Difficulty urinating

  • Prolonged urination time

  • Difficulty emptying the bladder

  • Urgency (sudden urge to urinate)

  • Frequent urination

  • Nocturia (waking up at night to urinate)

  • Urinary incontinence

Evaluation
Patient complaints are assessed using the IPSS (International Prostate Symptom Score). Digital rectal examination (DRE), blood PSA (Prostate-Specific Antigen) testing, and urinalysis are necessary diagnostic procedures. DRE and PSA testing help urologists distinguish between benign and malignant prostate enlargements.

Treatment Options
Surgical treatment is applied to patients who develop complications due to prostate enlargement, whose symptoms do not improve despite medication, or who prefer a more effective treatment method. The choice of surgical method depends on the size of the prostate, the patient’s general health status, the presence of other medical conditions, medications being used for those conditions, and several other factors. Based on this assessment, either open or minimally invasive (endoscopic) surgical procedures are performed. About 90% of cases are treated with minimally invasive techniques, which can be performed under spinal, epidural, or general anesthesia.

Endoscopic (minimally invasive) prostate surgery technologies used depending on the patient’s condition include:

 

  • Monopolar (conventional) TURP

  • Bipolar (plasma kinetic) TURP

  • GreenLight Laser

MRI Fusion

Regular prostate screenings play a crucial role in the early diagnosis and prevention of prostate cancer. With MRI Fusion Biopsy — a more sensitive method in prostate cancer screening — cases that cannot be detected with standard biopsy can be identified, eliminating suspicion of cancer and avoiding the need for repeat biopsies.

Male Infertility Treatment – Varicocele

Varicocele refers to the enlargement of the veins that carry blood from the testicles, causing blood to flow backward. It occurs in the left testicle in about 85% of cases (due to the left testicular vein draining into the left renal vein, which is under higher pressure and farther away) and bilaterally in about 15% of cases. If varicocele is seen only on the right side, further evaluation is required.

About 15–20% of marriages experience difficulty in conceiving at the desired time and number of children. In infertility cases, male-related factors alone account for about 20%, while in approximately 40% of couples, male factors contribute alongside female factors. Overall, in 50–60% of couples struggling with infertility, male-related problems at least partially contribute to the condition. While most male infertility problems can be diagnosed with physical examination and semen analysis, some cases require special tests.

The initial evaluation of male infertility starts with a consultation with a urologist-andrologist and providing a semen sample under proper conditions, evaluated according to WHO (World Health Organization) criteria in at least two separate sperm analyses (spermiograms).

If abnormalities are detected in the initial examination or sperm analysis, more detailed tests will follow, including advanced sperm function tests, hormone analyses, ultrasonography, and certain radiological or genetic studies. After the evaluation, treatments aim to increase the number, motility, and quality of sperm cells in the semen, thereby improving fertilization capacity.

Some men with infertility problems can be treated by replacing missing hormones or using medications to increase sperm count in patients with suitable hormonal profiles.

Varicocele Treatment

The most technically successful and least complication-prone method for varicocele surgery is microsurgery. In microsurgical varicocelectomy, the technical success rate can exceed 99%, with the rate of serious complications dropping to 0% and minor complications to 3–5%. In other surgical techniques, the risk of hydrocele can reach 40%, and arterial injury up to 5%.

In varicocele treatment, the embolization method — a radiological intervention — is not preferred due to low success rates and high rates of serious complications. Microsurgical varicocelectomy is not a simple surgical procedure; it requires specialized training and experience. Inadequate or incorrect application of microsurgery can lead to serious complications, even organ loss.

Patients with persistent varicocele or complications such as hydrocele or testicular loss after unsuccessful varicocele surgeries performed with microsurgery or older techniques are not uncommon. Some patients whose sperm quality or semen parameters have worsened — sometimes to zero — may benefit from corrective microsurgery, while others cannot be helped.

Varicocele can also be a cause of pain. While complete pain relief cannot be guaranteed, applying microsurgical techniques and pain-focused surgical methods can eliminate pain in many cases.

 

 

Testicular Cancer

Testicular cancer is a type of cancer that develops in one or both testicles of young men. It is highly treatable and curable.

The testicles are organs of the male reproductive system. In an adult male, each testicle is slightly smaller than a golf ball and is located in a sac called the scrotum, beneath the penis.

The testicles produce testosterone, the male sex hormone. They are also responsible for sperm production. Sperm cells produced in the testicles travel to the seminal vesicles through the vas deferens (sperm duct). Here, sperm mixes with fluid produced by the prostate gland. During ejaculation, sperm cells, seminal vesicle fluid, and prostate secretions enter the urethra — the channel in the penis that carries both urine and semen.

The testicles are made up of various types of cells. Each cell type can produce one or more types of cancer. Distinguishing between these cancer types is crucial, as diagnosis and treatment vary according to the type of cancer cells involved.

Seminomas

Seminomas develop from the germ cells in the testicles that produce sperm. There are two main types of seminomas: classic (typical) seminomas and spermatocytic seminomas.

Doctors determine the type by examining the cancer cells under a microscope. More than 95% of seminomas are of the classic type. These typically occur in men from their late 30s to early 50s.

Spermatocytic seminomas occur in older men, with the average age at diagnosis being around 55 — about 10–15 years older than the average for classic seminomas. They tend to grow more slowly than classic seminomas and are less likely to spread to other parts of the body.

Nonseminomas

This type of germ cell tumor occurs in men from the end of puberty to the early 40s. There are four main types of nonseminoma tumors: embryonal carcinoma, yolk sac carcinoma, choriocarcinoma, and teratoma. Most tumors are a mixture of at least two different types; however, this does not change the treatment approach. All nonseminomas are treated using the same methods.

Embryonal Carcinoma
This type of nonseminoma germ cell tumor accounts for about 40% of testicular tumors. Pure embryonal carcinoma occurs in only 3–4% of cases. Under the microscope, these tumors resemble the appearance of an embryo at a very early stage of development. Embryonal carcinomas tend to grow rapidly and spread beyond the testis.

Yolk Sac Carcinoma
These tumors are named for their resemblance to the yolk sac of an early human embryo. Other names include endodermal sinus tumors, childhood embryonal carcinoma, or orchidoblastoma. Yolk sac tumors are the most common type of testicular cancer in children and are highly treatable in this age group. In adults, however, they are more concerning, especially when pure (not mixed with other nonseminoma types). Yolk sac carcinomas, even when spread, respond very well to chemotherapy. These tumors release a protein called alpha-fetoprotein (AFP) into the blood. The presence of AFP in the blood is useful in diagnosis and in monitoring a patient’s response to treatment.

Choriocarcinoma
Choriocarcinomas are very rare and highly aggressive cancers in adults. They tend to spread quickly to distant organs such as the lungs, bones, and brain. Pure choriocarcinoma is uncommon in the testis, but it is often found as part of mixed germ cell tumors along with other nonseminoma types.

Teratomas
Under the microscope, teratomas are composed of cells from all three embryonic layers: endoderm (inner layer), mesoderm (middle layer), and ectoderm (outer layer). There are three main types: mature teratoma, immature teratoma, and teratoma with malignant transformation.

 

  • Mature teratomas are made up of well-developed adult-like tissue cells. They rarely spread to nearby tissues or distant organs and are usually treated surgically. Sometimes, after chemotherapy for mixed germ cell nonseminomas, residual mature teratomas may remain. These may be leftover parts of the tumor that chemotherapy did not destroy. Some experts believe chemotherapy can transform nonseminomas into teratomas.

  • Immature teratomas contain underdeveloped cancerous cells resembling early embryos. Unlike mature teratomas, immature teratomas invade nearby tissues and can spread outside the testis (metastasis). They may also recur (relapse) years after treatment.

  • Teratomas with malignant transformation are extremely rare. In some areas, they resemble mature teratomas, while in other areas they behave like cancers that typically occur outside the testis (such as cancers of the muscle, lungs, intestinal glands, or brain).

Stromal Tumors

Tumors can also develop in the supportive and hormone-producing tissues of the testis, known as the stroma. These are called gonadal stromal tumors. They account for about 4% of testicular cancers in adults but 20% of testicular cancers in children. The two main types are Leydig cell tumors and Sertoli cell tumors.

Leydig Cell Tumors
These tumors develop from Leydig cells, which normally produce male sex hormones (androgens, such as testosterone). Leydig cell tumors occur in both adults (75% of cases) and children (25% of cases). They usually produce androgens but can sometimes produce estrogen (female sex hormones). Most Leydig cell tumors do not spread beyond the testis and can be treated with surgery. However, in rare cases, they can metastasize (spread to other parts of the body). If metastasis occurs, the treatment success rate is low because these tumors generally do not respond well to radiation therapy or chemotherapy.

Sertoli Cell Tumors
These tumors develop from Sertoli cells, which support and nourish sperm-producing cells. Like Leydig cell tumors, they are usually benign (non-spreading). However, if they do spread, they are resistant to chemotherapy and radiotherapy.

Secondary Testicular Tumors
Secondary testicular tumors are cancers that start in another organ and spread to the testis. Lymphoma is the most common secondary testicular tumor. In men over the age of 50, testicular lymphoma is more common than primary testicular tumors. General treatment involves surgical removal of the tumor, followed by radiotherapy and/or chemotherapy. In children with leukemia, leukemia cells can sometimes form tumors in the testis.

Cancers from the prostate, lung, skin (melanoma), kidney, and other organs can also spread to the testis. However, the prognosis is generally poor because the cancer has already spread to other organs. Treatment is determined based on the type of primary cancer.

 

Treatment Of Testicular Tumors

Regardless of stage or diagnosis, the standard treatment for all testicular tumors is surgical removal of the testis through an open radical inguinal orchiectomy. Depending on the pathology results after surgery, additional treatments such as chemotherapy, radiotherapy, or RPLND (retroperitoneal lymph node dissection) may be required.

Kidney Cancer

Many different types of cancer can develop in the kidney. These types are classified into two groups: benign (non-cancerous) and malignant (cancerous). The most common mass seen in the kidney is a simple renal cyst. A kidney cyst is a benign mass and is completely different from cancer. In most cases, kidney cysts are discovered incidentally and never pose a threat to human life. Patients diagnosed with a kidney cyst often panic unnecessarily and seek treatment; however, in reality, kidney cysts usually do not require any treatment at all—regular monitoring is almost always sufficient.

 

Kidney cancer, on the other hand, is a malignant mass and, unlike kidney cysts, can pose a threat to human life. For the purpose of this article, we will focus on renal cell carcinoma, the most common malignant kidney tumor in adults. Renal cell carcinoma originates from the tissues in the kidney that filter the blood and produce urine. As kidney cancer grows, it may spread to nearby lymph nodes, the liver, large intestine, and pancreas. Additionally, fragments of the main tumor can break off and travel to distant parts of the body, where they can settle and grow (metastasis).

Possible Causes of Kidney Cancer

Kidney cancer usually occurs between the ages of 50 and 70 and is seen 2–3 times more frequently in men than in women. The exact cause of kidney cancer is still unknown. However, researchers have identified several risk factors that may increase the likelihood of developing the disease. It is important to note that not everyone with these risk factors will develop kidney cancer, and not all kidney cancer patients have these factors.

 

  • Smoking: Studies have shown that the risk of kidney cancer is twice as high in smokers. This risk increases with the number of cigarettes smoked per day and the duration of smoking. Quitting smoking gradually reduces the elevated risk over time.

  • Family history: Having a relative with kidney cancer increases the risk.

  • Diet: High-calorie diets and fried foods increase the risk.

  • High blood pressure: Some studies indicate that people with high blood pressure are three times more likely to develop kidney cancer.

  • Obesity: Excess weight, especially in women, may increase the risk.

  • Occupational risk factors: People working in the steel industry, petroleum sector, cadmium and lead industries, and those exposed to asbestos have a higher risk.

  • Radiation: Individuals who have previously received radiation therapy or have been exposed to radiation for other reasons carry an increased risk.

  • Dialysis: Patients with chronic kidney failure who have been on long-term hemodialysis have a higher risk of developing kidney cysts and kidney cancer.

  • Genetics: Von Hippel–Lindau disease is a hereditary condition that may cause cancer to develop in both kidneys and other organs. These patients and their families should be closely monitored.

Symptoms of Kidney Cancer

In its early stages, kidney cancer may not cause any noticeable symptoms. Kidney cancers detected incidentally are often treatable. In other words, when diagnosed early, treatment becomes easier, and the chance of complete recovery increases. However, as the tumor grows and spreads, treatment possibilities decrease. The best approach is not to skip routine check-ups, as this increases the likelihood of early detection and recovery.
Still, one or more of the following symptoms may occur, listed in order of frequency:

  • Blood in the urine: Sometimes visible to the naked eye and may appear intermittently. In some cases, it can only be detected through urine analysis.

  • Mass in the kidney area

  • Pain

  • Loss of appetite

  • General feeling of illness

  • Weight loss

  • Recurrent high fever

  • High blood pressure (hypertension)

  • Anemia

If the cancer has spread, symptoms related to the affected organ may appear. For example:

 

  • Lung metastasis: Cough, shortness of breath, coughing up blood

  • Bone metastasis: Bone pain

  • Brain metastasis: Headache, paralysis, loss of consciousness

 

 

Kidney Cancer Treatment

The treatment of a kidney tumor is determined according to the patient’s age, general health condition, and the extent (stage) of the cancer’s spread. Surgery is the standard method in the treatment of kidney cancers. Depending on the stage, size, and number of the cancer, either the kidney, the adrenal gland, and the surrounding membrane and fatty tissue are completely removed through a radical nephrectomy, or only the tumor is removed through a partial nephrectomy.

The surgical technique, whether open surgery or the method called laparoscopic (closed surgery), is decided by the surgeon. If the remaining kidney is normal, removing the diseased kidney does not cause any problems regarding kidney functions. Depending on the surgical technique, the patient can usually be discharged from the hospital shortly after the surgery (3–4 days). After being discharged, it is possible to return comfortably to normal daily activities. According to your doctor’s recommendation, you should return to the hospital later for reassessment of your condition. This follow-up is absolutely necessary in order to evaluate your general condition after the surgery and to plan the future course of your disease. This follow-up examination is also the most appropriate time to share all the details of your illness with your doctor.

The removed specimens are examined using the histopathology method to determine the type, character, and extent of the tumor. This both confirms the diagnosis and provides information about the spread.

If the cancer is inside the Gerota’s fascia, in most patients no additional treatment is required. If the tumor has spread outside the fascia or is present in another location, additional treatment will be necessary after surgery.

Kidney Stones

A kidney stone, medically known as nephrolithiasis or urolithiasis, refers to hard mineral deposits that accumulate in the kidneys.
If substances such as calcium oxalate or uric acid are found in urine at higher-than-normal concentrations, kidney stones may form. These substances can crystallize in the kidney, and over time, the crystals grow to form a stone. Stones can move or travel down the urinary tract and be expelled from the body. However, if a stone becomes lodged anywhere along the urinary tract and blocks the flow of urine, it often causes severe, typical kidney pain, which is widely feared.

Risk Factors

Certain medical conditions and lifestyle habits can trigger the risk of kidney stone formation.
People who have previously had calcium stones are at a higher risk of recurrence. The likelihood of forming another stone after the first episode is about 15% within one year and 80% within 10 years.

Patients with gout or high uric acid levels in their urine have an increased risk of kidney stones. Some medications that promote crystal formation can also raise the risk. Frequent or persistent diarrhea or dehydration, leading to concentrated, acidic urine, can contribute to stone development.

Other risk factors include:

  • Urinary tract infections

  • Structural abnormalities of the kidney

  • Kidney diseases (e.g., renal tubular acidosis, polycystic kidney disease)

  • Dietary habits

  • Insufficient fluid intake

  • Living in hot climates

  • Hypercalciuria, cystinuria, hyperoxaluria, hyperuricosuria

  • Certain medications (e.g., acetazolamide, some antiviral drugs)

  • Some intestinal diseases (e.g., inflammatory bowel disease)

  • Genetic factors

  • History of bowel surgery (e.g., jejunoileal bypass)

  • Metabolic disorders (e.g., hyperparathyroidism, gout)

Prevention:

  • Drink plenty of fluids, especially water (at least 2.5 liters daily).

Symptoms

Pain is the most common symptom of kidney stones. For some people, kidney pain may be a mild, barely noticeable ache, while in others, it can be extremely severe, excruciating, and intense enough to require hospitalization.

Pain attacks are caused by the movement of the stone within the ureter and the associated spasms. Severe pain episodes typically last between 20 and 60 minutes. Kidney pain occurs on the same side of the body as the stone.

  • Stones in the kidney or upper ureter cause flank pain between the ribs and hips.

  • Stones in the lower ureter or near the bladder cause pain in the lower abdomen, sometimes radiating to the genital area.

Other symptoms may include:

 

  • Blood in the urine

  • Nausea and vomiting

  • Burning sensation during urination

  • Frequent urge to urinate

  • Occasionally, kidney stones may cause no symptoms and are discovered incidentally during routine check-ups or imaging for other reasons.

How Can I Prevent It?

Dietary habits play a major role in stone formation. By paying attention to your diet, it is possible to significantly reduce the risk of kidney stones:

 

  • Avoid consuming acidic beverages such as cola and soda whenever possible.

  • Reduce tea and coffee intake.

  • Grapefruit juice and apple juice may increase the risk of kidney stones; on the other hand, pure lemon juice can be protective.

  • Completely avoiding milk and dairy products increases the risk of stone formation. Diets lacking calcium should not be followed. Consume milk, yogurt, and cheese in moderation.

  • Choose high-fiber foods.

  • Limit excessive intake of high-oxalate foods such as beetroot, soy, black tea, chocolate, cocoa, dried figs, black pepper, hazelnuts, parsley, poppy seeds, spinach, strawberries, blackberries, etc.

  • People with a history of kidney stones should limit the consumption of beer and other alcoholic drinks, anchovies, sardines, organ meats, legumes, mushrooms, spinach, asparagus, cauliflower, and meat.

  • Reduce salt intake.

  • Engage in regular physical activity without putting strain on the body.

  • Lead a stress-free lifestyle.

Kidney Stone Treatment Options

1- Flexible Ureterorenoscopy (Flexible URS), Retrograde Intrarenal Surgery (RIRS, RIRC)
One of the latest technologies in the treatment of kidney stones is the Flexible URS method, which allows complete removal of stones in the kidney entirely endoscopically (without any incision). In this method, once the kidney is reached endoscopically, the stones are visualized via camera and fragmented using a laser. This technique has a very high success rate, and another advantage is that the hospital stay is limited to just one day.

2- ESWL (Extracorporeal Shock Wave Lithotripsy)
Shock waves originating from a focal point are directed at the stone to break it down. Devices are available that focus using X-ray or ultrasound. The broken stone fragments are passed out of the body through the urinary tract. ESWL cannot achieve success in all stones. Success depends on the type, hardness, size, and location of the stone in the urinary tract. While some stones can be broken in a single session, others may require repeated sessions. Discomfort and pain may be felt during the ESWL session, so painkillers are administered before treatment. In most cases, hospital admission is not necessary after the procedure. This is one of the main methods applicable to most patients requiring interventional treatment. It is considered a good treatment option especially for stones located within the kidney and in the upper ureter. However, it is not suitable for stones larger than 2 cm, very hard stones, or those completely filling the kidney. In this method, high-energy shock waves are directed precisely to the stone, progressing without damaging the skin or internal organs, and causing fragmentation at the stone’s surface. The stone is then broken into small pieces, allowing for easy passage through the urinary tract.

3- Percutaneous Nephrolithotomy (PCNL)
In endoscopic kidney stone surgery, a 0.5–1 cm incision is made in the back area at the level of the kidney. Under X-ray guidance, a thin tube open at both ends is placed into the kidney. Using an optical device inserted through this tube, the stone is visualized on a monitor and removed with special instruments. The most significant advantage of percutaneous surgery is the preservation of the normal structure of body tissues, resulting in a faster recovery process. Patients experience a much more comfortable postoperative period compared to open surgery and are generally discharged within 2–3 days, quickly resuming daily activities. This is a much shorter period compared to open kidney stone surgery. Particularly in stones located in the lower calyces of the kidney and in large stones, ESWL success rates decrease significantly. In such cases, PCNL is a minimally invasive procedure with a high success rate. During surgery, pneumatic lithotripsy and laser lithotripsy are used to break the stones. With these technologies, even the hardest stones can be broken easily. This technique can also be applied to stones covering the entire kidney, known as staghorn stones.

4- Ureterolithotripsy
Ureteral stones can be removed by intervention with ureterorenoscopy (URS). In URS, no incision is made. A special endoscopic instrument is passed through the urinary tract to visualize and remove the stone in the ureter. Most patients can return home the same day and resume normal activities the next day. The success rate is especially high in stones located in the lower and middle ureter (96–100% success). Ureteroscopy is used to remove stones that cause obstruction in the lower and middle parts of the ureter. In ureteroscopic procedures, a very thin telescopic instrument is inserted through the urethra and bladder into the ureter. With this thin and flexible endoscope, the stone causing the obstruction is reached and removed. One year after the first stone episode, patients are checked with ultrasound and direct imaging. During this period, to prevent recurrence, patients must pay particular attention to fluid intake.

 

Dear Patient,
All of these treatment options are available at our hospital. For more detailed information, please contact us.

Infertility Treatment – Microtese

Infertility in men accounts for approximately half of couples who are unable to have children in today’s society. In other words, in half of the couples with infertility, there is also a male factor. In addition to male-related causes such as azoospermia (absence of sperm cells in men) and retrograde ejaculation (backward release of sperm cells), treatment should be initiated without waiting for factors related to the woman, such as age. The ICSI (Intracytoplasmic Sperm Injection) method has made it possible for men who have no sperm in their semen (the whitish, sticky fluid containing male reproductive cells released from the penis during ejaculation) to have children. However, for this procedure to be performed, the man must produce at least a small amount of sperm cells in the testicles. In other words, the sperm must be obtained from the person himself.

Obtaining sperm cells from the testicles is done by different methods depending on the patient’s condition. In men whose semen analysis (male fluid without sperm cells) shows no sperm cells, a testicular biopsy can be performed. This procedure aims to determine the cause of the absence of sperm cells — whether it is due to the inability to produce sperm cells, a blockage, or another reason for the absence of sperm cells in the semen.

TESE (Testicular Sperm Extraction) is a procedure performed to find small areas in the testicles where sperm cells are produced in patients with severe sperm production disorders. Tiny tissue samples of millimeter size are taken from several sites within the testicles, and the presence of sperm cells is checked. Micro TESE is the process of finding sperm cells within the sperm-producing tubules of the testicles using a microscope. In men with sperm production disorders not caused by a blockage, this procedure offers a 36% to 68% chance of finding sperm cells.

With the Micro TESE procedure, the chance of finding sperm cells during each biopsy increases while removing less testicular tissue. Compared to conventional TESE, the Micro TESE method has a higher sperm retrieval rate. Another advantage is that during the biopsy, damage to blood vessels and nerves in the testicular area is minimized, and the embryologist can more easily locate sperm cells in small tissue samples. After Micro TESE, the patient is kept under observation for 2 to 3 hours due to the general anesthesia and can be discharged home. For 7 days, heavy physical activities, long journeys, and prolonged driving should be avoided.

In Micro TESE, since the patient must remain still for a long period, general anesthesia is preferred over local anesthesia. Under the microscope, testicular structures are examined in detail at 20x magnification, and samples are taken from areas where sperm production is present. During the testicular incision (surgical cut), areas with fewer blood vessels are chosen under the microscope, which minimizes bleeding during the procedure. This also allows preservation of the vessels that provide blood supply to the testicles. Since very small amounts of tissue are removed (70 times less than multiple-site biopsies), there is no decrease in testosterone (male hormone) levels in the blood.

Retrieving sperm cells from the testicles can be performed under general or local anesthesia. In procedures performed under local anesthesia, sperm cells can be obtained by needle aspiration from the testicles or by removing a small sample of testicular tissue via a minor incision. These methods are chosen when sperm production within the testicles is certain or when the absence of sperm cells in semen is due to a blockage.

 

In addition to Micro TESE, in men with sperm production disorders and no sperm cells in semen, sperm retrieval under a microscope from the testicles (Microdissection TESE) can be performed. This method also uses general anesthesia.

Bladder Cancer

Uncontrolled growth of the cells that make up the bladder is called bladder cancer. Bladder cancer originates from the layer of cells lining the inside of the bladder. If this cell growth is limited only to the superficial layer of the bladder, it is called superficial bladder cancer. If the cell growth deepens and extends into the muscle and fat layer, it is called invasive bladder cancer.

 

Bladder cancer that has reached the muscle layer can spread to surrounding tissues. Through the bloodstream, it can reach other tissues and cause distant metastases, potentially spreading to organs such as the lungs or liver.

Bladder Cancer – Symptoms and Risk Groups


Although the exact cause of this disease has not been determined, it can occur at any age. However, since it is mostly seen in individuals over the age of 60, it can be considered a disease of older age. It is three times more common in men than in women, and the most significant risk factor is smoking.

Compared to non-smokers, smokers are 10 times more likely to develop this cancer. It is also frequently observed in individuals with a genetic predisposition and those exposed to chemicals for long periods (such as workers in the paint, rubber, and leather industries).

The risk of bladder cancer increases in individuals with recurrent urinary tract infections, those with kidney stones, and those who need to use a catheter for extended periods.

Symptoms of Bladder Cancer

  • Visible blood in the urine

  • Burning sensation during urination

  • Pain during urination and frequent urge to urinate

Since these complaints are similar to those of a simple urinary tract infection, they are often not taken seriously. However, especially in individuals in the risk group, these symptoms should prompt an immediate visit to the doctor.

Examinations Required for Diagnosis

  • Urinalysis, urine culture

  • Ultrasound examination

  • Kidney X-ray (IVP or CT scan)

  • Cystoscopy (procedure to examine the bladder using a lighted camera system)

Treatment of Bladder Cancer

Surgery is a treatment method used in many patients with bladder cancer. Surgical alternatives are listed below:

Transurethral Resection (TUR):

In stage 0 and 1 bladder cancer, the tumor can be removed with the help of a cystoscope under general or spinal anesthesia. Using the cystoscope, a cutting instrument is sent into the bladder to remove the tumor. TUR surgery can be repeated, and chemotherapy or biological therapy may be applied after this type of surgery. For a few days after TUR, blood in the urine and pain during urination may be observed.

Open Surgery:

A urological surgeon removes part or all of the bladder through an incision in the body.

Partial Cystectomy:

If there is a single and small tumor in the bladder, the surgeon may not need to remove the entire bladder, and only a portion of the bladder is removed. After this type of surgery, there may be issues with urinary control, but they can improve over time.

 

Radical Cystectomy:

This is the removal of the entire bladder. In stage II and III bladder cancers, the entire bladder is removed. The surgeon removes the bladder, surrounding lymph nodes, and part of the urethra. Additionally, in male patients, the prostate is removed, and in female patients, the uterus is removed. Since the bladder is removed, the surgeon either creates a new bladder from a section of the intestine or connects the urinary tract to an external bag for urine collection.

Urinary Incontinence

The bladder is an organ located behind the muscles below the navel, in front of the intestines in men, and below the uterus in women. It is a pouch where urine coming from the kidneys is stored.

When urine from the kidneys starts to fill the bladder, signals are sent to the brain through the nerves. In response, the brain sends signals to both prevent the bladder from contracting and to keep the muscles responsible for holding urine contracted. However, when the accumulated urine in the bladder starts to approach capacity, the signals sent to the brain increase, prompting the brain to direct the person to the toilet and release the pressure. As a result, the bladder muscle contracts, the muscles holding the urine relax, and the person urinates. In a normal adult, the bladder (urinary pouch) can hold about 350–500 ml of urine.

As urine accumulates, the bladder expands due to its elasticity, preventing an increase in internal pressure, which allows urine to flow freely from the kidneys into the bladder. Additionally, muscles located just below the bladder, which are continuously contracted, prevent the stored urine from leaking. In women, the urethra (urinary tract) is anatomically shorter than in men, and certain hormones provide additional support to the urethra.

There are many causes of urinary incontinence. These include bladder infections (cystitis in women), vaginal infections, bladder stones, tumors, difficult childbirth, hormonal changes after menopause, radiation therapy to the abdominal area, neurological diseases, and bladder outlet obstructions caused by conditions such as prostate enlargement in men.

Other causes of continuous urinary incontinence in women may include connections (fistulas) between the bladder and vagina or between the ureter (urine tube connecting the kidney to the bladder) and the vagina. Urinary incontinence can also be seen in uncontrolled diabetes and alcoholism.

Past surgeries in both men and women can lead to urinary incontinence. In men, surgeries for prostate cancer, other prostate surgeries, bladder neck surgeries, and operations around the bladder and urinary control mechanisms may cause this problem.

Certain medications can also cause or contribute to urinary incontinence. These include muscle relaxants, antihypertensive drugs, diuretics, sedatives, antidepressants, and allergy medications.

Diseases that cause a slowdown in brain function (such as dementia, Alzheimer’s, and vascular diseases) can also lead to urinary incontinence.

Urinary Incontinence After Vaginal Delivery

The muscles that hold the bladder in place may tear or become damaged during vaginal delivery. Normally, when coughing or sneezing, the bladder moves downward slightly. The supporting muscle tissue underneath prevents further movement, thus preventing urine leakage. However, damage or tearing of these surrounding muscles may prevent adequate support, causing the bladder to descend more than normal during coughing or sneezing, which leads to urine leakage.

Diagnosis:

Diagnosis involves taking a detailed medical history, performing a physical examination, using a daily urinary diary, conducting a pad test to measure the amount of urine leakage, and, if necessary, performing urodynamic tests to evaluate bladder function.

Urodynamics is particularly used for patients who continue to have urinary incontinence despite previous surgery and for those who will undergo surgery. During this procedure, a catheter is placed into the bladder, allowing valuable information to be obtained about how the bladder functions and the causes of urinary incontinence.

Surgical Treatment:

Surgical treatment is applied to patients who do not benefit from medical therapy or exercise-based methods.

In recent years, understanding that stress incontinence (urine leakage during coughing or sneezing) is mainly due to insufficient pelvic floor support has led to the abandonment of bladder-lifting techniques. Instead, a special material is surgically placed under the bladder base like a hammock to prevent further downward movement. This method, called TVT (Trans Vaginal Tape), is a very simple, same-day procedure that does not require hospitalization and can even be performed under local anesthesia.

 

This technique has been a significant advancement in urinary incontinence treatment. Scientific studies have shown that its long-term results are highly satisfactory. The success rate is over 90% in the early period, and even five years after surgery, the success rate remains above 80%.

Prostate Enlargement

BPH (Benign Prostatic Hyperplasia) is one of the most common conditions affecting middle-aged and older men. Its incidence increases with age. Approximately 20% of patients require surgical intervention, while 80% are recommended monitoring and medical treatment.

 

BPH symptoms include frequent urination, nighttime urination, and incomplete bladder emptying, which cause a gradual decline in quality of life. Under the influence of testosterone, known as the male hormone, the prostate enlarges and narrows the section of the urethra passing through it, leading to intermittent urination and weakened urine flow.

Symptoms

In BPH, a group of complaints known as lower urinary tract symptoms (LUTS) may occur:

 

  • Weak urine stream

  • Intermittent urination

  • Straining to urinate

  • Prolonged urination time

  • Difficulty emptying the bladder

  • Urgency to urinate

  • Frequent urination

  • Nocturia (waking at night to urinate)

  • Urinary incontinence

Evaluation

Patient complaints are assessed using the IPSS (International Prostate Symptom Score). Digital rectal examination, blood PSA (Prostate-Specific Antigen) measurement, and urinalysis are essential evaluations. Digital rectal examination and PSA testing help urologists distinguish between benign and malignant prostate enlargements.

Treatment Options

Surgical treatment is applied to patients who have complications due to prostate enlargement, show no improvement despite medical treatment, or prefer a more effective treatment option. The choice of surgical method depends on factors such as prostate size, the patient’s overall health condition, presence of other diseases, medications used for these conditions, and other relevant considerations. Based on this evaluation, either open or minimally invasive surgical procedures are performed. In 90% of patients, minimally invasive methods can be used. These operations can be performed under spinal, epidural, or general anesthesia.

Depending on the patient’s condition, the endoscopic (minimally invasive) prostate surgery technologies used include:

 

  • Monopolar (conventional) TUR

  • Bipolar (plasma kinetic) TUR

  • Greenlight laser

MRI Fusion

Early detection through regular prostate screenings plays a crucial role in preventing prostate cancer. MRI Fusion Biopsy, a more sensitive method in prostate cancer screening, can detect cases that standard biopsy may miss, eliminate suspicion of cancer, and prevent the need for repeated biopsies.

Date Added: 20 August 2025
Emsey Medical Editorial Board
Department Doctors
Prof. Hikmet KÖSEOĞLU
Urology
Meet the Doctor
Fill out the form for Urology
This field is required
This field is required
This field is required, please enter an email
By checking the box, I consent to the processing of my personal data within the scope of Law No. 6698 on the Protection of Personal Data (KVKK).
Please check the box